Skip to content

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction

Randomized Pilot Study of Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01890317
Acronym
SHOCK-COOL
Enrollment
40
Registered
2013-07-01
Start date
2012-08-31
Completion date
2016-03-31
Last updated
2018-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute; Myocardial Infarction, Complications, Cardiogenic Shock

Keywords

Cardiogenic shock, acute myocardial infarction, mild hypothermia

Brief summary

Prospective, randomized, single-center, controlled, open-label Pilot-study to investigate whether induction of mild hypothermia in addition to primary percutaneous coronary intervention and optimal medical therapy in myocardial infarction complicated by cardiogenic shock improves cardiac power index after 24 h.

Interventions

Induction of mild hypothermia with invasive cooling for 24 hr in addition to primary percutaneous coronary intervention and optimal medical therapy.

Sponsors

University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Acute myocardial infarction complicated by cardiongenic shock * Patients on mechanical ventilation at time of randomization

Exclusion criteria

* Out of hospital resuscitation with indication for mild hypothermia * mechanical complications after acute myocardial infarction * duration of cardiogenic shock \> 12 hours * age \> 90 years

Design outcomes

Primary

MeasureTime frameDescription
Cardiac Power Index after 24 hr.24 hoursCardiac Power Index after 24 hours as surrogate endpoint.

Secondary

MeasureTime frameDescription
Change of hemodynamics over the first 48 hr.During first 48 hr
Catecholamine dose and duration of catecholamine support30 days
Length of ICU-stay30 days
Length of mechanical ventilation30 days
30-days mortality30 days
Severe and moderate bleeding complications (GUSTO-definition)30 days
Sepsis30 days
Pneumonia30 days
Stroke30 days
SAPS-II-Score96 hoursSimplified Acute Physiology Score for the first 4 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026